Events for Food and Drug Administration (FDA)

Brand Companies at Risk for Products Manufactured by Generic Firms: California's Conte v. Wyeth Decision

Sign up your entire team to learn:

* How the Conte v. Wyeth ruling can put your company at risk for products manufactured by generic firms
* Steps to take immediately to prepare for future claims by plaintiffs
* How to leverage your case into federal court — and why to do it
* Tips for evaluating whether to assert a preemption defense
* Battle-tested strategies for developing and asserting a preemption defense
* How to counter a plaintiff’s “changes being effected” argument that drugmakers can make labeling changes before FDA approval
* The FDA’s current position — and goals — on preemption

View the Event

Share or bookmarklet this web page at: